Bill > SF4978

This bill modifies the rules for the Formulary Committee, which advises on which drugs are covered by Minnesota's medical assistance program. Key changes include allowing committee members with a potential conflict of interest to participate in discussions and communications, provided their conflict is publicly disclosed at least 48 hours before a relevant meeting. The bill also mandates that the commissioner of human services establish a public comment process for recommendations made to the committee and requires the committee to seek expertise from the Minnesota Rare Disease Advisory Council, particularly for drugs treating rare diseases or orphan drugs, before making decisions on prior authorization or preferred drug list placement. Additionally, the bill streamlines the prior authorization process for certain liquid medications used by patients with feeding tubes and extends the expiration date of the Formulary Committee.

Health and Social Services

https://www.revisor.mn.gov/bills/94/2026/0/SF/4978/